Holen Sie sich die Stockscreener-App
1.03
0.96%
-0.01
Handel nachbörslich:
1.03
Schlusskurs vom Vortag:
$1.04
Offen:
$1.07
24-Stunden-Volumen:
643.72K
Relative Volume:
1.64
Marktkapitalisierung:
$39.80M
Einnahmen:
$40.93M
Nettoeinkommen (Verlust:
$-15.57M
KGV:
-2.7666
EPS:
-0.3723
Netto-Cashflow:
$-17.84M
1W Leistung:
+17.29%
1M Leistung:
+24.94%
6M Leistung:
+19.30%
1J Leistung:
-66.88%
1-Tages-Spanne:
$1.01
$1.07
1-Wochen-Bereich:
$0.8695
$1.10
52-Wochen-Spanne:
$0.605
$3.22
Myomo Inc Stock (MYO) Company Profile
Firmenname
Myomo Inc
Sektor
Branche
Telefon
617-996-9058
Adresse
One Broadway, 14th Floor, Cambridge, MA
Compare MYO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
1.03 | 40.18M | 40.93M | -15.57M | -17.84M | -0.3723 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-31 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-20 | Eingeleitet | Lake Street | Buy |
| 2023-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2020-05-27 | Eingeleitet | Dougherty & Company | Buy |
| 2017-10-02 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Myomo Inc Aktie (MYO) Neueste Nachrichten
MYO: Wearable robotics drive growth with expanding reimbursement and recurring revenue focus - TradingView
MYO: Recurring revenue and expanded payer coverage fuel growth and improved financial outlook - TradingView
MYO: Recurring revenue and expanded coverage drive growth, with 2026 revenue guided at $43–$46 million - TradingView
Myomo reiterates $40M–$42M 2025 revenue target as O&P channel, MyoConnect drive growth - MSN
Myomo director Kirk Thomas F buys $68,242 in company stock By Investing.com - Investing.com Nigeria
Myomo (MYO) director adds 75,006 shares through open‑market buying - Stock Titan
Myomo director Kirk Thomas F buys $68,242 in company stock - Investing.com
Myomo | 4: Statement of changes in beneficial ownership of securities-Director KIRK THOMAS F - Moomoo
Horton Capital (MYO) reports 6% Myomo stake, wins board role and pushes declassification - Stock Titan
Myomo director Manko Jr. acquires $173,907 in MYO stock - Investing.com
Myomo director Manko Jr. acquires $173,907 in MYO stock By Investing.com - Investing.com India
Director-linked Horton Capital fund boosts Myomo (NYSE: MYO) stake with open-market buys - Stock Titan
MYOMO (MYO) director Joseph M. Manko Jr. reports 2.1M-share indirect stake - Stock Titan
MYO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MYO SEC FilingsMyomo 10-K, 10-Q, 8-K Forms - Stock Titan
Myomo (MYO) CCO sells 90,231 shares, retaining 109,478-share stake - Stock Titan
H.C. Wainwright Maintains Myomo(MYO.US) With Buy Rating, Maintains Target Price $5 - Moomoo
Myomo, Inc. (MYO) reports Q1 loss, beats revenue estimates - MSN
MYO (NYSE) Form 144: Broker lists 90,231 restricted shares for resale - Stock Titan
Myomo Appoints Joseph M. Manko to Board - Moomoo
Myomo Adds Horton Capital Executive to Board of Directors - The Globe and Mail
[ARS] MYOMO, INC. SEC Filing - Stock Titan
Myomo Announces Participation in Upcoming Investor Conferences - The Joplin Globe
Myomo (NYSE: MYO) 2026 proxy targets share increase, equity plan and declassified board vote - Stock Titan
Safeguard Scientifics stock (US78437J1007): Myomo appoints Safeguard director to board - AD HOC NEWS
Myomo appoints Joseph M. Manko to its board - Medical Buyer
Here is why bargain hunters would love fast-paced mover Myomo (MYO) - MSN
Earnings call transcript: Myomo beats Q1 2026 expectations, stock dips - Investing.com
Earnings call transcript: Myomo beats Q1 2026 expectations, stock dips By Investing.com - Investing.com Nigeria
Myomo appoints Joseph Manko to board of directors - Investing.com UK
Myomo Appoints Joseph M. Manko to its Board of Directors - 01net
Myomo appoints Joseph M. Manko to its board of directors - marketscreener.com
Myomo Appoints Joseph M. Manko To Its Board Of Directors - TradingView
Myomo appoints Joseph Manko to board of directors By Investing.com - Investing.com Australia
Joseph M. Manko joins Myomo (MYO) board, expanding it to seven directors - Stock Titan
Myomo, Inc. Appoints Joseph M. Manko Jr. as Director, Effective May 9, 2026 - marketscreener.com
Here Is Why Bargain Hunters Would Love Fast-paced Mover Myomo (MYO) - Yahoo Finance
A. G. P. Maintains Myomo(MYO.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Myomo revenue up 49% to USD 10.1M in Q1 2026 - Medical Buyer
Maxim Group Maintains Myomo(MYO.US) With Buy Rating, Maintains Target Price $3 - Moomoo
Q1 2026 Myomo Inc Earnings Call Transcript - GuruFocus
Myomo, Inc. (MYO) Reports Q1 2026 Revenue of $10.1 Million - GuruFocus
Myomo Q1 2026 Earnings Call Transcript - MarketBeat
Myomo Reports First Quarter 2026 Financial and Operating Results - BioSpace
Myomo outlines $10.3M-$10.8M Q2 revenue while reiterating $43M-$46M for 2026 - MSN
Finanzdaten der Myomo Inc-Aktie (MYO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):